-
EP2807164
European procedure
Extract from the Register of European Patents
EP About this file: EP2807164
| EP2807164 - IMIDAZOPYRROLIDINONE COMPOUNDS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 09.02.2018 Database last updated on 03.09.2024 | |
| Former | The patent has been granted Status updated on 03.03.2017 | ||
| Former | Grant of patent is intended Status updated on 24.02.2017 | Most recent event Tooltip | 09.02.2018 | No opposition filed within time limit | published on 14.03.2018 [2018/11] | Applicant(s) | For all designated states Novartis AG Lichtstrasse 35 4056 Basel / CH | [2014/49] | Inventor(s) | 01 /
FURET, Pascal Novartis Pharma AG Werk Klybeck Postfach 4002 Basel / CH | 02 /
GUAGNANO, Vito Novartis Pharma AG Werk Klybeck Postfach 4002 Basel / CH | 03 /
HOLZER, Philipp Novartis Pharma AG Werk Klybeck Postfach 4002 Basel / CH | 04 /
KALLEN, Joerg Novartis Pharma AG Postfach 4002 Basel / CH | 05 /
LIAO, Lv Beijing Novartis Pharma Co. Ltd. Room 402 Pu Ruan Building No. 2 Boyun Road Shanghai 201203 / CN | 06 /
MAH, Robert Novartis Pharma AG Werk Klybeck Postfach 4002 Basel / CH | 07 /
MAO, Liang Beijing Novartis Pharma Co. Ltd. Room 402 Pu Ruan Building No. 2 Boyun Road Shanghai 201203 / CN | 08 /
MASUYA, Keiichi Novartis Pharma AG Werk Klybeck Postfach 4002 Basel / CH | 09 /
SCHLAPBACH, Achim Novartis Pharma AG Postfach 4002 Basel / CH | 10 /
STUTZ, Stefan Novartis Pharma AG Werk Klybeck Postfach 4002 Basel / CH | 11 /
VAUPEL, Andrea Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | [2017/14] |
| Former [2014/49] | 01 /
FURET, Pascal Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | ||
| 02 /
GUAGNANO, Vito Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | |||
| 03 /
HOLZER, Philipp Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | |||
| 04 /
KALLEN, Joerg Novartis Pharma AG Postfach CH-4002 Basel / CH | |||
| 05 /
LIAO, Lv Beijing Novartis Pharma Co. Ltd. Room 402 Pu Ruan Building No. 2 Boyun Road Shanghai 201203 / CN | |||
| 06 /
MAH, Robert Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | |||
| 07 /
MAO, Liang Beijing Novartis Pharma Co. Ltd. Room 402 Pu Ruan Building No. 2 Boyun Road Shanghai 201203 / CN | |||
| 08 /
MASUYA, Keiichi Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | |||
| 09 /
SCHLAPBACH, Achim Novartis Pharma AG Postfach CH-4002 Basel / CH | |||
| 10 /
STUTZ, Stefan Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | |||
| 11 /
VAUPEL, Andrea Novartis Pharma AG Werk Klybeck Postfach CH-4002 Basel / CH | Representative(s) | Strang, Andrea Josephine, et al Novartis Pharma AG Patent Department Lichtstrasse 35 4056 Basel / CH | [N/P] |
| Former [2017/14] | Strang, Andrea Josephine, et al Novartis Pharma AG Lichtstrasse 35 4056 Basel / CH | ||
| Former [2014/49] | Hodge, Emma Jane Novartis Pharmaceuticals AG Patent Department Posfach 4002 Basel / CH | Application number, filing date | 13711952.5 | 25.01.2013 | [2017/14] | WO2013IB50655 | Priority number, date | US201261591001P | 26.01.2012 Original published format: US 201261591001 P | US201261669902P | 10.07.2012 Original published format: US 201261669902 P | WO2012CN86703 | 14.12.2012 Original published format: PCT/CN2012/086703 | [2014/49] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2013111105 | Date: | 01.08.2013 | Language: | EN | [2013/31] | Type: | A1 Application with search report | No.: | EP2807164 | Date: | 03.12.2014 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.08.2013 takes the place of the publication of the European patent application. | [2014/49] | Type: | B1 Patent specification | No.: | EP2807164 | Date: | 05.04.2017 | Language: | EN | [2017/14] | Search report(s) | International search report - published on: | EP | 01.08.2013 | Classification | IPC: | C07D487/04, A61K31/4188, A61P35/00 | [2014/49] | CPC: |
C07D487/04 (EP,CN,KR,US);
A61K31/4188 (KR,US);
A61K31/4439 (US);
A61K31/501 (KR,US);
A61K31/506 (US);
A61K31/5377 (KR,US);
A61K31/541 (US);
A61K45/06 (US);
A61P35/00 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2014/49] | Extension states | BA | 26.08.2014 | ME | 26.08.2014 | Title | German: | IMIDAZOPYRROLIDINONVERBINDUNGEN | [2014/49] | English: | IMIDAZOPYRROLIDINONE COMPOUNDS | [2014/49] | French: | COMPOSÉS IMIDAZOPYRROLIDINONE | [2014/49] | Entry into regional phase | 26.08.2014 | National basic fee paid | 26.08.2014 | Designation fee(s) paid | 26.08.2014 | Examination fee paid | Examination procedure | 26.08.2014 | Examination requested [2014/49] | 24.03.2015 | Amendment by applicant (claims and/or description) | 18.09.2015 | Despatch of a communication from the examining division (Time limit: M06) | 16.03.2016 | Reply to a communication from the examining division | 13.05.2016 | Communication of intention to grant the patent | 06.09.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 22.09.2016 | Communication of intention to grant the patent | 10.10.2016 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 21.10.2016 | Communication of intention to grant the patent | 21.02.2017 | Fee for grant paid | 21.02.2017 | Fee for publishing/printing paid | 21.02.2017 | Receipt of the translation of the claim(s) | Divisional application(s) | EP16161001.9 / EP3064502 | EP17182338.8 / EP3272754 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 18.09.2015 | Opposition(s) | 08.01.2018 | No opposition filed within time limit [2018/11] | Fees paid | Renewal fee | 13.01.2015 | Renewal fee patent year 03 | 11.01.2016 | Renewal fee patent year 04 | 11.01.2017 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2003153580 (KONG NORMAN [US], et al) [A] 1-32 * claim 1 * * page 2, paragraph [0025] *; | [A]US2011230457 (BERGHAUSEN JOERG [CH], et al) [A] 1-32 * claim 1 ** page 1, paragraph [0006] * |